Kemnay Advisory Services Inc. Abb Vie Inc. Transaction History

Kemnay Advisory Services Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $35,344 - $44,720	-329 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $818,195 - $900,734	-7,998 Reduced 96.05%	329 $36,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $643,759 - $869,142	7,998 Added 2431.0%	8,327 $892,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $24,138 - $32,301	329 New	329 $32,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Kemnay Advisory Services Inc., based on Form 13F filings with the SEC.

Stay updated on Kemnay Advisory Services Inc. with notifications on news.